|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kleeff J, Korc M, Apte M, La Vecchia C,
Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH
and Neoptolemos JP: Pancreatic cancer. Nat Rev Dis Primers.
2:160222016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dougan SK: The pancreatic cancer
microenvironment. Cancer J. 23:321–325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lei MZ, Li XX, Zhang Y, Li JT, Zhang F,
Wang YP, Yin M, Qu J and Lei QY: Acetylation promotes BCAT2
degradation to suppress BCAA catabolism and pancreatic cancer
growth. Signal Transduct Target Ther. 5:702020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quamme GA: Molecular identification of
ancient and modern mammalian magnesium transporters. Am J Physiol
Cell Physiol. 298:C407–C429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chaigne-Delalande B, Li FY, O'Connor GM,
Lukacs MJ, Jiang P, Zheng L, Shatzer A, Biancalana M, Pittaluga S,
Matthews HF, et al: Mg2+ regulates cytotoxic functions of NK and
CD8 T cells in chronic EBV infection through NKG2D. Science.
341:186–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cazzaniga A, Moscheni C, Trapani V, Wolf
FI, Farruggia G, Sargenti A, Lotti S, Maier J and Castiglioni S:
The different expression of TRPM7 and MagT1 impacts on the
proliferation of colon carcinoma cells sensitive or resistant to
doxorubicin. Sci Rep. 7:405382017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li H, Xia T, Guan Y and Yu Y: Sevoflurane
regulates glioma progression by Circ_0002755/miR-628-5p/MAGT1 axis.
Cancer Manag Res. 12:5085–5098. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Molee P, Adisakwattana P, Reamtong O,
Petmitr S, Sricharunrat T, Suwandittakul N and Chaisri U:
Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in
progressive hepatocellular carcinoma: A novel target for prognosis.
Int J Clin Exp Pathol. 8:9796–9811. 2015.PubMed/NCBI
|
|
12
|
Wang G, Li Y, Li J, Zhang D, Luo C, Zhang
B and Sun X: microRNA-199a-5p suppresses glioma progression by
inhibiting MAGT1. J Cell Biochem. 120:15248–15254. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng K, Yang Q, Xie L, Qiu Z, Huang Y,
Lin Y, Tu L and Cui C: Overexpression of MAGT1 is associated with
aggressiveness and poor prognosis of colorectal cancer. Oncol Lett.
18:3857–3862. 2019.PubMed/NCBI
|
|
14
|
Zheng L, Xue J, Jaffee EM and Habtezion A:
Role of immune cells and immune-based therapies in pancreatitis and
pancreatic ductal adenocarcinoma. Gastroenterology. 144:1230–1240.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen QB, Liang YK, Zhang YQ, Jiang MY, Han
ZD, Liang YX, Wan YP, Yin J, He HC and Zhong W: Decreased
expression of TCF12 contributes to progression and predicts
biochemical recurrence in patients with prostate cancer. Tumour
Biol. 39:10104283177039242017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao J, Wei J, Yang P, Zhang T, Chen Z, He
F, Wei F, Chen H, Hu H, Zhong J, et al: Genome-scale CRISPR-Cas9
knockout screening in gastrointestinal stromal tumor with Imatinib
resistance. Mol Cancer. 17:1212018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
L'Abbate A, Tolomeo D, De Astis F, Lonoce
A, Lo Cunsolo C, Mühlematter D, Schoumans J, Vandenberghe P, Van
Hoof A, Palumbo O, et al: t(15;21) translocations leading to the
concurrent downregulation of RUNX1 and its transcription factor
partner genes SIN3A and TCF12 in myeloid disorders. Mol Cancer.
14:2112015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao S, Bian T, Zhang Y, Su M and Liu Y:
TCF12 overexpression as a poor prognostic factor in ovarian cancer.
Pathol Res Pract. 215:1525272019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee CC, Chen WS, Chen CC, Chen LL, Lin YS,
Fan CS and Huang TS: TCF12 protein functions as transcriptional
repressor of E-cadherin, and its overexpression is correlated with
metastasis of colorectal cancer. J Biol Chem. 287:2798–2809. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen WS, Chen CC, Chen LL, Lee CC and
Huang TS: Secreted heat shock protein 90α (HSP90α) induces nuclear
factor-κB-mediated TCF12 protein expression to down-regulate
E-cadherin and to enhance colorectal cancer cell migration and
invasion. J Biol Chem. 288:9001–9010. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang J, Zhang L, Jiang Z, Ge C, Zhao F,
Jiang J, Tian H, Chen T, Xie H, Cui Y, et al: TCF12 promotes the
tumorigenesis and metastasis of hepatocellular carcinoma via
upregulation of CXCR4 expression. Theranostics. 9:5810–5827. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Gao S, Xie F, Li W, Li M, Yan N,
Gao T and Fang L: High expression of TCF12 contributes to gastric
cancer development via being target regulated by miR-183 and
activating PI3K/AKT pathway. J Cell Biochem. 120:13903–13911. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He J, Shen S, Lu W, Zhou Y, Hou Y, Zhang
Y, Jiang Y, Liu H and Shao Y: HDAC1 promoted migration and invasion
binding with TCF12 by promoting EMT progress in gallbladder cancer.
Oncotarget. 7:32754–32764. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo C, Balsa E, Perry EA, Liang J, Tavares
CD, Vazquez F, Widlund HR and Puigserver P: H3K27me3-mediated PGC1α
gene silencing promotes melanoma invasion through WNT5A and YAP. J
Clin Invest. 130:853–862. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Si L, Fu J, Liu W, Hayashi T, Nie Y,
Mizuno K, Hattori S, Fujisaki H, Onodera S and Ikejima T: Silibinin
inhibits migration and invasion of breast cancer MDA-MB-231 cells
through induction of mitochondrial fusion. Mol Cell Biochem.
463:189–201. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gobin E, Bagwell K, Wagner J, Mysona D,
Sandirasegarane S, Smith N, Bai S, Sharma A, Schleifer R and She
JX: A pan-cancer perspective of matrix metalloproteases (MMP) gene
expression profile and their diagnostic/prognostic potential. BMC
Cancer. 19:5812019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou H and Clapham DE: Mammalian MagT1 and
TUSC3 are required for cellular magnesium uptake and vertebrate
embryonic development. Proc Natl Acad Sci USA. 106:15750–15755.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gile J, Ruan G, Abeykoon J, McMahon MM and
Witzig T: Magnesium: The overlooked electrolyte in blood cancers?
Blood Rev. 44:1006762020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ravell J, Chaigne-Delalande B and Lenardo
M: X-linked immunodeficiency with magnesium defect, Epstein-Barr
virus infection, and neoplasia disease: A combined immune
deficiency with magnesium defect. Curr Opin Pediatr. 26:713–719.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Willis S, Villalobos VM, Gevaert O,
Abramovitz M, Williams C, Sikic BI and Leyland-Jones B: Single gene
prognostic biomarkers in ovarian cancer: A meta-analysis. PLoS One.
11:e01491832016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Auwercx J, Rybarczyk P, Kischel P,
Dhennin-Duthille I, Chatelain D, Sevestre H, Van Seuningen I,
Ouadid-Ahidouch H, Jonckheere N and Gautier M: Mg(2+) transporters
in digestive cancers. Nutrients. 13:2102021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie J, Cheng CS, Zhu XY, Shen YH, Song LB,
Chen H, Chen Z, Liu LM and Meng ZQ: Magnesium transporter protein
solute carrier family 41 member 1 suppresses human pancreatic
ductal adenocarcinoma through magnesium-dependent Akt/mTOR
inhibition and bax-associated mitochondrial apoptosis. Aging
(Albany NY). 11:2681–2698. 2019. View Article : Google Scholar : PubMed/NCBI
|
